Hanwha Chemical Co., a unit of South Korea's Hanwha Group, will sell its stake in its wholly owned pharmaceutical unit Dreampharma Corp., company and industry sources said Wednesday. Hanwha Chemical picked Citigroup Global Markets Korea Securities Ltd. as a manager of the deal, the sources said.